DE
63
3
ADT
53
3
MRK
25
-2
NDAQ
62
2
CVX
47
3
RIG
60
2
DTE
56
2
ORCL
65
-2
LNC
39
3
CMG
72
5
WFC
79
4
PGR
65
2
DFS
64
2
GE
67
2
PFE
23
7
BF.B
33
2
IPG
56
3
MCHP
41
4
PVH
62
5
UNP
52
7
DE
63
3
ADT
53
3
MRK
25
-2
NDAQ
62
2
CVX
47
3
RIG
60
2
DTE
56
2
ORCL
65
-2
LNC
39
3
CMG
72
5
WFC
79
4
PGR
65
2
DFS
64
2
GE
67
2
PFE
23
7
BF.B
33
2
IPG
56
3
MCHP
41
4
PVH
62
5
UNP
52
7
Financhill
Back

Virtus LifeSci Biotech Clinical Trls ETF Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35

BBC
Virtus LifeSci Biotech Clinical Trls ETF

Last Price:
26.53
Seasonality Move:
8.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Virtus LifeSci Biotech Clinical Trls ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trls ETF has on average historically risen by 2.9% based on the past 9 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trls ETF has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Virtus LifeSci Biotech Clinical Trls ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $26.85. The Score for BBC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trls ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trls ETF has on average historically risen by 2.9% based on the past 9 years of stock performance.

Virtus LifeSci Biotech Clinical Trls ETF Stock Rating

Sell
35
Virtus LifeSci Biotech Clinical Trls ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trls ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trls ETF has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Virtus LifeSci Biotech Clinical Trls ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.99
52-Week Low:
18.77

Prediction Charts

Market Cap:
0
Price in USD:
26.85
Volume:
2.29K
Beta:
1.29

Technical Analysis

SMA50:
28.66
SMA100:
28.12
SMA200:
27.79
52-Wk Change:
42.01%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trls ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trls ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trls ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trls ETF stock price is 26.85 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trls ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trls ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 28.92 29.54 29.54 28.89
Nov-6 29.95 30.60 30.60 29.95
Nov-7 30.73 30.72 30.85 30.66
Nov-8 30.82 31.05 31.05 30.82
Nov-11 31.37 31.34 31.65 31.34
Nov-12 30.79 29.83 30.79 29.83
Nov-13 30.07 29.28 30.48 29.28
Nov-14 29.23 28.35 29.25 28.35
Nov-15 28.00 26.53 28.00 26.53
Nov-18 26.50 26.10 26.51 26.09
Nov-19 26.01 26.34 26.34 25.81
Nov-20 26.13 26.17 26.35 26.00
Nov-21 25.98 26.12 26.32 25.91
Nov-22 26.84 26.85 26.91 26.84

Virtus LifeSci Biotech Clinical Trls ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trls ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trls ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.